Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03063710

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:55.624193+00:00

Published At

2018-05-17T00:00:00+00:00

Record Updated At

2018-05-17

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["PSR Ovarian Cancer With a BRCA Mutation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-05-17"

protocolSection.identificationModule.nctId

"NCT03063710"

protocolSection.identificationModule.officialTitle

"Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients"

protocolSection.statusModule.overallStatus

"NO_LONGER_AVAILABLE"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• PSR Ovarian Cancer With a BRCA Mutation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.